Correlation Between Mineralys Therapeutics, and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Puma Biotechnology, you can compare the effects of market volatilities on Mineralys Therapeutics, and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Puma Biotechnology.
Diversification Opportunities for Mineralys Therapeutics, and Puma Biotechnology
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mineralys and Puma is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Puma Biotechnology
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Puma Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 1.24 times less risky than Puma Biotechnology. The stock trades about -0.06 of its potential returns per unit of risk. The Puma Biotechnology is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 321.00 in Puma Biotechnology on September 13, 2024 and sell it today you would lose (29.00) from holding Puma Biotechnology or give up 9.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Puma Biotechnology
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Puma Biotechnology |
Mineralys Therapeutics, and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Puma Biotechnology
The main advantage of trading using opposite Mineralys Therapeutics, and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Mineralys Therapeutics, vs. Commonwealth Bank of | Mineralys Therapeutics, vs. Celsius Holdings | Mineralys Therapeutics, vs. Vita Coco | Mineralys Therapeutics, vs. Glacier Bancorp |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |